AstraZeneca PLC (AZN)
LSE
Closed
Sep 16, 2026
Day's Range
12,074.0052 wk Range
9,892.00Overview - AZN - AstraZeneca PLC
Key Statistics
Valuation
Enterprise Value
159.56B
P/E (Trailing)
‪24.56‬
P/E (Forward)
‪14.32‬
PEG Ratio
‪12.93‬
Price / Sales (TTM)
‪3.06‬
Price / Book
‪506.25‬
EV / EBITDA
‪10.82‬
Profitability
Gross Margin
‪83.59%‬
Profit Margin
‪17.02%‬
Operating Margin
‪23.45%‬
Return on Assets
‪8.01%‬
Return on Equity
‪21.96%‬
Ownership
Shares Outstanding
1.55B
Float
1.54B
Held by Insiders
‪0.04%‬
Held by Institutions
‪64.92%‬
Price stats
Beta
‪0.20‬
50-Day Avg
‪12,243.48‬
200-Day Avg
‪13,648.56‬
Dividends
Payout Ratio
‪47.41%‬
Frequency
Semi-Annual
Analyst Consensus
25 analysts
Average price target
‪£ 15,641.62‬Market Cap - AZN - AstraZeneca PLC
Peers - AZN - AstraZeneca PLC
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on LSE.
- AZNLSEAstraZeneca PLC19.27TMarket Cap+9.73%52-week change24.57P/E (Trailing)‪17.02%‬Profit Margin
- GSKLSEGSK plc7.52TMarket Cap+19.52%52-week change16.10P/E (Trailing)‪14.52%‬Profit Margin
- SANLSESantander UK Plc Preferred Stock 10.375% Perpetual4.72TMarket Cap+98.91%52-week change0.38P/E (Trailing)‪19.73%‬Profit Margin
- 0QIULSENovo Nordisk A/S1.06TMarket Cap-37.73%52-week change17.11P/E (Trailing)‪33.39%‬Profit Margin
- 0Q1GLSEEli Lilly and Company984.08BMarket Cap+26.67%52-week change1.49P/E (Trailing)‪33.52%‬Profit Margin
- 0QCVLSEAbbVie Inc.476.72BMarket Cap+16.79%52-week change54.53P/E (Trailing)‪15.50%‬Profit Margin
- ZEGLSEZegona Communications Plc397.03BMarket Cap+24.52%52-week change167.00P/E (Trailing)‪-5.22%‬Profit Margin
Profile Summary - AZN - AstraZeneca PLC
About
AstraZeneca PLC is a global biopharmaceutical company that discovers, develops, manufactures, and commercializes prescription medicines. AstraZeneca PLC focuses on major therapeutic areas including oncology, rare diseases, cardiovascular, renal and metabolism, respiratory and immunology, and vaccines and immune…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
